Mayne Pharma Group (OTCMKTS:MAYNF) Stock Falls 8.8% – Here’s What Happened

Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) traded down 8.8% during trading on Friday. The stock traded as low as $1.87 and last traded at $1.87. 8,135 shares were traded during mid-day trading, an increase of 139% from the average daily volume of 3,405 shares. The stock had previously closed at $2.05.

Mayne Pharma Group Trading Down 8.8%

The stock has a fifty day moving average price of $2.22 and a two-hundred day moving average price of $1.90.

Mayne Pharma Group Company Profile

(Get Free Report)

Mayne Pharma Group is an Australian specialty pharmaceutical company that develops, manufactures and commercializes branded, generic and specialty medicines. Its portfolio has included prescription products in areas such as women’s health, dermatology and oral and transdermal drug delivery.

The company has also provided pharmaceutical development and contract manufacturing services, supporting the formulation, production and commercialization of medicines for other pharmaceutical companies.

See Also

• Five stocks we like better than Mayne Pharma Group
• Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
• Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
• Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
• Arista Networks Plugs Into All-Time Highs